Literature DB >> 7904014

Treatment of Clostridium difficile diarrhoea with brewer's yeast.

D Schellenberg, A Bonington, C M Champion, R Lancaster, S Webb, J Main.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7904014     DOI： 10.1016/s0140-6736(94)90960-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Clostridium difficile infection of the gut.

Authors:  A P Dodson; S P Borriello
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

3.  Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae.

Authors:  R L Brandão; I M Castro; E A Bambirra; S C Amaral; L G Fietto; M J Tropia; M J Neves; R G Dos Santos; N C Gomes; J R Nicoli
Journal:  Appl Environ Microbiol       Date:  1998-02       Impact factor: 4.792

4.  Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.

Authors:  Bruno Douradinha; Viviane C B Reis; Matthew B Rogers; Fernando A G Torres; Jared D Evans; Ernesto T A Marques
Journal:  Bioengineered       Date:  2013-09-05       Impact factor: 3.269

5.  Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).

Authors:  M J McCullough; K V Clemons; J H McCusker; D A Stevens
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 6.  Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis.

Authors:  Aloysius L D'Souza; Chakravarthi Rajkumar; Jonathan Cooke; Christopher J Bulpitt
Journal:  BMJ       Date:  2002-06-08

7.  Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat.

Authors:  F Izadnia; C T Wong; S A Kocoshis
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

8.  Functional pentameric formation via coexpression of the Escherichia coli heat-labile enterotoxin B subunit and its fusion protein subunit with a neutralizing epitope of ApxIIA exotoxin improves the mucosal immunogenicity and protection against challenge by Actinobacillus pleuropneumoniae.

Authors:  Jung-Mi Kim; Seung-Moon Park; Jung-Ae Kim; Jin-Ah Park; Min-Hee Yi; Nan-Sun Kim; Jong-Lye Bae; Sung Goo Park; Yong-Suk Jang; Moon-Sik Yang; Dae-Hyuk Kim
Journal:  Clin Vaccine Immunol       Date:  2011-10-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.